Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia.

Ana Fontalba, Africa Fernandez-L, Eva Garcia Alegria, Virginia Albinana, Eva M. Garrido-Martin, Francisco J. Blanco, Roberto Zarrabeitia, Alfonso Perez-Molino, Maria E. Bernabeu-Herrero, Maria-Luisa Ojeda, Jose L. Fernandez-Luna, Carmelo Bernabeu, Luisa M. Botella

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND:
Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant and age-dependent vascular disorder characterised mainly by mutations in the Endoglin (ENG) or activin receptor-like kinase-1 (ALK1, ACVRL1) genes.
METHODS:
Here, we have identified 22 ALK1 mutations and 15 ENG mutations, many of which had not previously been reported, in independent Spanish families afflicted with HHT.
RESULTS:
We identified mutations in thirty-seven unrelated families. A detailed analysis of clinical symptoms was recorded for each patient analyzed, with a higher significant presence of pulmonary arteriovenous malformations (PAVM) in HHT1 patients over HHT2. Twenty-two mutations in ALK1 and fifteen in ENG genes were identified. Many of them, almost half, represented new mutations in ALK1 and in ENG. Missense mutations in ENG and ALK1 were localized in a tridimensional protein structure model.
CONCLUSION:
Overall, ALK1 mutations (HHT2) were predominant over ENG mutations (HHT1) in our Spanish population, in agreement with previous data from our country and other Mediterranean countries (France, Italy), but different to Northern Europe or North America. There was a significant increase of PAVM associated with HHT1 over HHT2 in these families.
Original languageEnglish
Pages (from-to)295
JournalBMC Medical Genetics
Volume9
Issue number75
DOIs
Publication statusPublished - Aug 2008

Keywords

  • Missense mutation
  • Hereditary Hemorrharic Telangiectasia
  • Primary pulmonary hypertension
  • Hereditary Haemorrhagic Telangiectasia
  • Affected Member

Fingerprint

Dive into the research topics of 'Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia.'. Together they form a unique fingerprint.

Cite this